DK3124497T3 - Rationelt designede syntetiske antistofbiblioteker og anvendelser deraf - Google Patents
Rationelt designede syntetiske antistofbiblioteker og anvendelser deraf Download PDFInfo
- Publication number
- DK3124497T3 DK3124497T3 DK16169483.1T DK16169483T DK3124497T3 DK 3124497 T3 DK3124497 T3 DK 3124497T3 DK 16169483 T DK16169483 T DK 16169483T DK 3124497 T3 DK3124497 T3 DK 3124497T3
- Authority
- DK
- Denmark
- Prior art keywords
- rationale
- applications
- antibody libraries
- synthetic antibody
- designed synthetic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/005—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/567—Framework region [FR]
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/06—Biochemical methods, e.g. using enzymes or whole viable microorganisms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99378507P | 2007-09-14 | 2007-09-14 | |
| EP08830652.7A EP2193146B1 (en) | 2007-09-14 | 2008-09-12 | Rationally designed, synthetic antibody libraries and uses therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3124497T3 true DK3124497T3 (da) | 2020-05-11 |
Family
ID=40350153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16169483.1T DK3124497T3 (da) | 2007-09-14 | 2008-09-12 | Rationelt designede syntetiske antistofbiblioteker og anvendelser deraf |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US8691730B2 (da) |
| EP (3) | EP3753947A1 (da) |
| JP (6) | JP5933894B2 (da) |
| CN (1) | CN101855242B (da) |
| AU (1) | AU2008298603B2 (da) |
| BR (1) | BRPI0816785A2 (da) |
| CA (3) | CA2964398C (da) |
| DK (1) | DK3124497T3 (da) |
| HK (1) | HK1147271A1 (da) |
| MX (3) | MX344415B (da) |
| WO (1) | WO2009036379A2 (da) |
Families Citing this family (208)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004009618A2 (en) | 2002-07-18 | 2004-01-29 | Crucell Holland B.V. | Recombinant production of mixtures of antibodies |
| US8288322B2 (en) | 2000-04-17 | 2012-10-16 | Dyax Corp. | Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries |
| EP1360288B1 (en) | 2000-12-18 | 2011-02-16 | Dyax Corp. | Focused libraries of genetic packages |
| USRE47770E1 (en) | 2002-07-18 | 2019-12-17 | Merus N.V. | Recombinant production of mixtures of antibodies |
| US20040067532A1 (en) | 2002-08-12 | 2004-04-08 | Genetastix Corporation | High throughput generation and affinity maturation of humanized antibody |
| US20100069614A1 (en) | 2008-06-27 | 2010-03-18 | Merus B.V. | Antibody producing non-human mammals |
| EP2395017A3 (en) | 2003-05-30 | 2012-12-19 | Merus B.V. | Design and use of paired variable regions of specific binding molecules |
| US8877688B2 (en) | 2007-09-14 | 2014-11-04 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
| DK3124497T3 (da) | 2007-09-14 | 2020-05-11 | Adimab Llc | Rationelt designede syntetiske antistofbiblioteker og anvendelser deraf |
| EP2098536A1 (en) | 2008-03-05 | 2009-09-09 | 4-Antibody AG | Isolation and identification of antigen- or ligand-specific binding proteins |
| US9873957B2 (en) | 2008-03-13 | 2018-01-23 | Dyax Corp. | Libraries of genetic packages comprising novel HC CDR3 designs |
| AU2009240481B2 (en) * | 2008-04-24 | 2015-07-30 | Takeda Pharmaceutical Company Limited | Libraries of genetic packages comprising novel HC CDR1, CDR2, and CDR3 and novel LC CDR1, CDR2, and CDR3 designs |
| US8067339B2 (en) | 2008-07-09 | 2011-11-29 | Merck Sharp & Dohme Corp. | Surface display of whole antibodies in eukaryotes |
| DK2435568T3 (da) * | 2009-05-29 | 2014-09-08 | Morphosys Ag | Samling af syntetiske antistoffer til behandling af sygdom |
| WO2011032181A2 (en) * | 2009-09-14 | 2011-03-17 | Dyax Corp. | Libraries of genetic packages comprising novel hc cdr3 designs |
| BR112012019887B1 (pt) | 2010-02-08 | 2021-06-08 | Regeneron Pharmaceuticals, Inc | método para fabricação de anticorpo e método para selecionar uma sequência de ácido nucleico da região variável da cadeia pesada humana para produzir um anticorpo |
| US9796788B2 (en) | 2010-02-08 | 2017-10-24 | Regeneron Pharmaceuticals, Inc. | Mice expressing a limited immunoglobulin light chain repertoire |
| US20130045492A1 (en) | 2010-02-08 | 2013-02-21 | Regeneron Pharmaceuticals, Inc. | Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain |
| WO2011100369A2 (en) * | 2010-02-09 | 2011-08-18 | The Trustees Of Columbia University In The City Of New York | Methods for altering polypeptide expression and solubility |
| US9044460B2 (en) * | 2010-05-04 | 2015-06-02 | Merrimack Pharmaceuticals, Inc. | Antibodies against epidermal growth factor receptor (EGFR) and uses thereof |
| WO2012009568A2 (en) * | 2010-07-16 | 2012-01-19 | Adimab, Llc | Antibody libraries |
| PL2640742T3 (pl) | 2010-11-19 | 2019-01-31 | Morphosys Ag | Kolekcja sekwencji przeciwciał i jej zastosowanie |
| DE102010056289A1 (de) * | 2010-12-24 | 2012-06-28 | Geneart Ag | Verfahren zur Herstellung von Leseraster-korrekten Fragment-Bibliotheken |
| US9260753B2 (en) | 2011-03-24 | 2016-02-16 | President And Fellows Of Harvard College | Single cell nucleic acid detection and analysis |
| US8691231B2 (en) | 2011-06-03 | 2014-04-08 | Merrimack Pharmaceuticals, Inc. | Methods of treatment of tumors expressing predominantly high affinity EGFR ligands or tumors expressing predominantly low affinity EGFR ligands with monoclonal and oligoclonal anti-EGFR antibodies |
| LT3572517T (lt) | 2011-08-05 | 2021-04-26 | Regeneron Pharmaceuticals, Inc. | Humanizuotos universalios lengvosios grandinės pelės |
| CA2791109C (en) | 2011-09-26 | 2021-02-16 | Merus B.V. | Generation of binding molecules |
| JP2015512245A (ja) | 2012-03-16 | 2015-04-27 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | ｐＨ依存性の結合特徴を有する抗原結合タンパク質を産生するマウス |
| US20140013456A1 (en) | 2012-03-16 | 2014-01-09 | Regeneron Pharmaceuticals, Inc. | Histidine Engineered Light Chain Antibodies and Genetically Modified Non-Human Animals for Generating the Same |
| RU2664473C2 (ru) | 2012-03-16 | 2018-08-17 | Регенерон Фармасьютикалз, Инк. | ОТЛИЧНЫЕ ОТ ЧЕЛОВЕКА ЖИВОТНЫЕ, ЭКСПРЕССИРУЮЩИЕ ЧУВСТВИТЕЛЬНЫЕ К pН ПОСЛЕДОВАТЕЛЬНОСТИ ИММУНОГЛОБУЛИНОВ |
| RU2017135754A (ru) | 2012-03-16 | 2019-02-08 | Регенерон Фармасьютикалз, Инк. | Антитела со встроенным в легкие цепи гистидином и генетически модифицированные отличные от человека животные для их получения |
| HUE025378T2 (hu) | 2012-04-17 | 2016-02-29 | Arsanis Biosciences Gmbh | Keresztreagáló Staphylococcus aureus ellenanyag |
| NZ799532A (en) | 2012-04-20 | 2023-07-28 | Merus Nv | Methods and means for the production of ig-like molecules |
| AU2013270684B2 (en) | 2012-06-08 | 2018-04-19 | Sutro Biopharma, Inc. | Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use |
| BR112015014991B1 (pt) | 2013-01-17 | 2024-01-23 | Janssen Pharmaceuticals, Inc | Anticorpo específico para e. coli mdr, plasmídeo, cassete de expressão, célula hospedeira, método de produção do anticorpo, método para identificar um anticorpo candidato, preparação farmacêutica e de diagnóstico, epítopo, imunogênio e ácido nucleico utilizados |
| RU2695146C2 (ru) * | 2013-01-31 | 2019-07-22 | Кодексис, Инк. | Способы, системы и программное обеспечение для идентификации биомолекул со взаимодействующими компонентами |
| EP2983710B1 (en) | 2013-04-09 | 2019-07-31 | Annexon, Inc. | Methods of treatment for neuromyelitis optica |
| WO2014187746A2 (en) | 2013-05-21 | 2014-11-27 | Arsanis Biosciences Gmbh | Generation of highly potent antibodies neutralizing the lukgh (lukab) toxin of staphylococcus aureus |
| DK3019240T3 (da) | 2013-07-09 | 2024-06-03 | Annexon Inc | Anti-komplementfaktor C1Q antistoffer og anvendelser deraf |
| ES2865473T3 (es) | 2013-07-10 | 2021-10-15 | Sutro Biopharma Inc | Anticuerpos que comprenden múltiples residuos de aminoácidos no naturales sitio-específicos, métodos para su preparación y métodos de uso |
| KR20160067977A (ko) | 2013-10-17 | 2016-06-14 | 알사니스 바이오사이언시스 게엠베하 | 교차반응성 스타필로코커스 아우레우스 항체 서열 |
| RU2724530C2 (ru) | 2014-02-06 | 2020-06-23 | Экс4 Фамасьютиклз (Остриэ) ГмбХ | Выделенное антитело (варианты), способ получения антитела, выделенная нуклеиновая кислота, экспрессионная кассета (варианты), плазмида (варианты), клетка-хозяин, фармацевтический препарат, набор, способ лечения больного, подверженного риску или страдающего от инфекции e.coli, и способ диагностики определения инфекций e.coli |
| AU2015230938C1 (en) | 2014-03-21 | 2021-10-14 | Regeneron Pharmaceuticals, Inc. | Non-human animals that make single domain binding proteins |
| EP3825326A1 (en) | 2014-04-01 | 2021-05-26 | Adimab, LLC | Multispecific antibody analogs comprising a common light chain, and methods of their preparation and use |
| MA39599A (fr) | 2014-05-14 | 2016-10-05 | Merrimack Pharmaceuticals Inc | Dosage et administration d'agents thérapeutiques anti-egfr |
| TWI695011B (zh) | 2014-06-18 | 2020-06-01 | 美商梅爾莎納醫療公司 | 抗ｈｅｒ２表位之單株抗體及其使用之方法 |
| EP3733700A1 (en) | 2014-07-14 | 2020-11-04 | The Penn State Research Foundation | Compositions and methods for targeting of the surfactant protein a receptor |
| EP3708227A1 (en) | 2014-07-22 | 2020-09-16 | Sutro Biopharma, Inc. | Anti-cd74 antibodies, compositions comprising anti-cd74 antibodies and methods of using anti-cd74 antibodies |
| EP3172325B1 (en) | 2014-07-22 | 2023-06-28 | The University of Notre Dame du Lac | Molecular constructs and uses thereof |
| EA201790342A1 (ru) | 2014-08-08 | 2017-07-31 | ЭЛЕКТОР ЭлЭлСи | Антитела к trem2 и способы их применения |
| EP3191605B1 (en) * | 2014-09-09 | 2022-07-27 | The Broad Institute, Inc. | A droplet-based method and apparatus for composite single-cell nucleic acid analysis |
| MA40835A (fr) | 2014-10-23 | 2017-08-29 | Biogen Ma Inc | Anticorps anti-gpiib/iiia et leurs utilisations |
| MA40861A (fr) | 2014-10-31 | 2017-09-05 | Biogen Ma Inc | Anticorps anti-glycoprotéines iib/iiia |
| EP3845565A3 (en) | 2014-11-19 | 2021-09-08 | Genentech, Inc. | Antibodies against bace1 and use thereof for neural disease immunotherapy |
| CN107250158B (zh) | 2014-11-19 | 2022-03-25 | 基因泰克公司 | 抗转铁蛋白受体/抗bace1多特异性抗体和使用方法 |
| KR101694832B1 (ko) * | 2014-12-31 | 2017-01-12 | 앱클론(주) | 항체 라이브러리 및 그의 제작방법 |
| US11466074B2 (en) | 2015-02-17 | 2022-10-11 | X4 Pharmaceuticals (Austria) GmbH | Antibodies targeting a galactan-based O-antigen of K. pneumoniae |
| CN107614700A (zh) | 2015-03-11 | 2018-01-19 | 布罗德研究所有限公司 | 基因型和表型偶联 |
| EP3271403A1 (en) | 2015-03-19 | 2018-01-24 | Regeneron Pharmaceuticals, Inc. | Non-human animals that select for light chain variable regions that bind antigen |
| EP3280441B1 (en) | 2015-04-07 | 2021-09-29 | Alector LLC | Anti-sortilin antibodies and methods of use thereof |
| AU2016245887B2 (en) | 2015-04-10 | 2021-09-23 | Adimab, Llc. | Methods for purifying heterodimeric multispecific antibodies from parental homodimeric antibody species |
| MX2017012775A (es) * | 2015-04-17 | 2019-04-29 | Arsanis Biosciences Gmbh | Preparacion combinatoria de anticuerpos anti-staphylococcus aureus. |
| WO2016177651A1 (en) * | 2015-05-01 | 2016-11-10 | Medimmune Limited | Novel phage display library, members thereof and uses of the same |
| EP3307779A2 (en) | 2015-06-12 | 2018-04-18 | Alector LLC | Anti-cd33 antibodies and methods of use thereof |
| WO2016201388A2 (en) | 2015-06-12 | 2016-12-15 | Alector Llc | Anti-cd33 antibodies and methods of use thereof |
| TWI715617B (zh) | 2015-08-24 | 2021-01-11 | 比利時商葛蘭素史密斯克藍生物品公司 | 對抗腸道外病原性大腸桿菌之免疫保護之方法及組合物 |
| AU2016316768A1 (en) | 2015-08-28 | 2018-03-29 | Alector Llc | Anti-Siglec-7 antibodies and methods of use thereof |
| JP7023233B2 (ja) | 2015-10-01 | 2022-02-21 | ポテンザ セラピューティックス インコーポレイテッド | 抗ｔｉｇｉｔ抗原結合タンパク質と、その使用方法 |
| US20190330335A1 (en) | 2015-10-06 | 2019-10-31 | Alector Llc | Anti-trem2 antibodies and methods of use thereof |
| AU2016336901A1 (en) | 2015-10-16 | 2018-05-10 | Arsanis Biosciences Gmbh | Bactericidal monoclonal antibody targeting Klebsiella pneumoniae |
| US11092607B2 (en) | 2015-10-28 | 2021-08-17 | The Board Institute, Inc. | Multiplex analysis of single cell constituents |
| WO2017075297A1 (en) | 2015-10-28 | 2017-05-04 | The Broad Institute Inc. | High-throughput dynamic reagent delivery system |
| EP3368575A2 (en) | 2015-10-29 | 2018-09-05 | Alector LLC | Anti-siglec-9 antibodies and methods of use thereof |
| WO2017087901A2 (en) | 2015-11-19 | 2017-05-26 | Sutro Biopharma, Inc. | Anti-lag3 antibodies, compositions comprising anti-lag3 antibodies and methods of making and using anti-lag3 antibodies |
| EP3402902B1 (en) | 2016-01-15 | 2021-10-27 | Massachusetts Institute Of Technology | Semi-permeable arrays for analyzing biological systems and methods of using same |
| KR102216032B1 (ko) * | 2016-01-19 | 2021-02-16 | 주무토르 바이오로직스 인코포레이티드 | 합성 항체 라이브러리의 생성 방법, 상기 라이브러리 및 그 적용(들) |
| JP7252760B2 (ja) | 2016-01-22 | 2023-04-05 | メルク・シャープ・アンド・ドーム・エルエルシー | 抗凝固因子ｘｉ抗体 |
| US11708413B2 (en) | 2016-01-27 | 2023-07-25 | Sutro Biopharma, Inc. | Anti-CD74 antibody conjugates, compositions comprising anti-CD74 antibody conjugates and methods of using anti-CD74 antibody conjugates |
| WO2017152102A2 (en) | 2016-03-04 | 2017-09-08 | Alector Llc | Anti-trem1 antibodies and methods of use thereof |
| JP6987072B2 (ja) | 2016-03-10 | 2021-12-22 | アクセレロン ファーマ インコーポレーテッド | アクチビン２型受容体結合タンパク質及びその使用 |
| KR102413037B1 (ko) | 2016-03-15 | 2022-06-23 | 메르사나 테라퓨틱스, 인코포레이티드 | Napi2b 표적화된 항체-약물 접합체 및 이의 사용 방법 |
| KR102379580B1 (ko) | 2016-06-14 | 2022-03-29 | 머크 샤프 앤드 돔 코포레이션 | 항응고 인자 xi 항체 |
| US11098107B2 (en) | 2016-06-15 | 2021-08-24 | Sutro Biopharma, Inc. | Antibodies with engineered CH2 domains, compositions thereof and methods of using the same |
| WO2018029346A1 (en) | 2016-08-12 | 2018-02-15 | Arsanis Biosciences Gmbh | Klebsiella pneumoniae o3 specific antibodies |
| US20190161534A1 (en) | 2016-08-12 | 2019-05-30 | Arsanis Biosciences Gmbh | Anti-galactan ii monoclonal antibodies targeting klebsiella pneumoniae |
| EP3293293A1 (en) * | 2016-09-08 | 2018-03-14 | Italfarmaco SpA | Hc-cdr3-only libraries with reduced combinatorial redundancy and optimized loop length distribution |
| US20190233512A1 (en) | 2016-10-12 | 2019-08-01 | Sutro Biopharma, Inc. | Anti-folate receptor antibodies, compositions comprising anti-folate receptor antibodies and methods of making and using anti-folate receptor antibodies |
| AR109621A1 (es) | 2016-10-24 | 2018-12-26 | Janssen Pharmaceuticals Inc | Formulaciones de vacunas contra glucoconjugados de expec |
| RS62589B1 (sr) | 2016-11-02 | 2021-12-31 | Jounce Therapeutics Inc | Antitela na pd-1 i njihova upotreba |
| JOP20190100A1 (ar) | 2016-11-19 | 2019-05-01 | Potenza Therapeutics Inc | بروتينات ربط مولد ضد مضاد لـ gitr وطرق استخدامها |
| TN2019000164A1 (en) | 2016-11-23 | 2020-10-05 | Bioverativ Therapeutics Inc | Mono- and bispecific antibodies binding to coagulation factor ix and coagulation factor x |
| EP3559037A1 (en) | 2016-12-22 | 2019-10-30 | Wake Forest University Health Sciences | Sirp-gamma targeted agents for use in the treatment of cancer |
| MX2019007356A (es) | 2016-12-23 | 2019-09-05 | Visterra Inc | Polipeptidos de union y metodos para fabricarlos. |
| JOP20190134A1 (ar) | 2016-12-23 | 2019-06-02 | Potenza Therapeutics Inc | بروتينات رابطة لمولد ضد مضادة لنيوروبيلين وطرق استخدامها |
| CN108239150A (zh) | 2016-12-24 | 2018-07-03 | 信达生物制药(苏州)有限公司 | 抗pcsk9抗体及其用途 |
| WO2018148447A1 (en) * | 2017-02-08 | 2018-08-16 | Adimab, Llc | Antibody heavy chain variable domains targeting the nkg2d receptor |
| WO2018148445A1 (en) | 2017-02-08 | 2018-08-16 | Adimab, Llc | Multi-specific binding proteins for activation of natural killer cells and therapeutic uses thereof to treat cancer |
| BR112019017197A2 (pt) | 2017-02-20 | 2020-04-14 | Dragonfly Therapeutics Inc | proteínas que se ligam a her2, nkg2d e cd16 |
| WO2018156785A1 (en) | 2017-02-22 | 2018-08-30 | Sutro Biopharma, Inc. | Pd-1/tim-3 bi-specific antibodies, compositions thereof, and methods of making and using the same |
| CN108623686A (zh) | 2017-03-25 | 2018-10-09 | 信达生物制药(苏州)有限公司 | 抗ox40抗体及其用途 |
| JOP20190203A1 (ar) | 2017-03-30 | 2019-09-03 | Potenza Therapeutics Inc | بروتينات رابطة لمولد ضد مضادة لـ tigit وطرق استخدامها |
| US11072816B2 (en) | 2017-05-03 | 2021-07-27 | The Broad Institute, Inc. | Single-cell proteomic assay using aptamers |
| WO2018213316A1 (en) | 2017-05-16 | 2018-11-22 | Alector Llc | Anti-siglec-5 antibodies and methods of use thereof |
| WO2018217944A1 (en) | 2017-05-24 | 2018-11-29 | Sutro Biopharma, Inc. | Pd-1/lag3 bi-specific antibodies, compositions thereof, and methods of making and using the same |
| CN110997723B (zh) | 2017-06-08 | 2023-09-26 | 黑带医疗有限公司 | Cd38调节抗体 |
| CN117534754A (zh) | 2017-06-08 | 2024-02-09 | 黑带医疗有限公司 | Cd38调节抗体 |
| CA3066774A1 (en) | 2017-06-22 | 2018-12-27 | Novartis Ag | Antibody molecules to cd73 and uses thereof |
| SG10201913147WA (en) | 2017-07-11 | 2020-02-27 | Compass Therapeutics Llc | Agonist antibodies that bind human cd137 and uses thereof |
| WO2019023316A1 (en) | 2017-07-26 | 2019-01-31 | Sutro Biopharma, Inc. | METHODS OF USING ANTI-CD74 ANTIBODIES AND ANTIBODY CONJUGATES IN THE TREATMENT OF A T CELL LYMPHOMA |
| US10961318B2 (en) | 2017-07-26 | 2021-03-30 | Forty Seven, Inc. | Anti-SIRP-α antibodies and related methods |
| WO2019023504A1 (en) | 2017-07-27 | 2019-01-31 | Iteos Therapeutics Sa | ANTI-TIGIT ANTIBODIES |
| BR112020001499A2 (pt) | 2017-07-27 | 2020-09-08 | Iteos Therapeutics Sa | anticorpos anti-tigit |
| CR20190486A (es) | 2017-08-03 | 2020-02-10 | Alector Llc | Anti-cd33 antibodies and methods of use thereof |
| MY201526A (en) | 2017-08-03 | 2024-02-27 | Alector Llc | Anti-trem2 antibodies and methods of use thereof |
| SG11202000484TA (en) | 2017-08-16 | 2020-02-27 | Black Belt Therapeutics Ltd | Cd38 antibody |
| KR20200036860A (ko) | 2017-08-16 | 2020-04-07 | 블랙 벨트 테라퓨틱스 리미티드 | Cd38 조정 항체 |
| UA128472C2 (uk) | 2017-08-25 | 2024-07-24 | Файв Прайм Терапеутікс Інк. | B7-h4 антитіла і методи їх використання |
| CN109422811A (zh) | 2017-08-29 | 2019-03-05 | 信达生物制药(苏州)有限公司 | 抗cd47抗体及其用途 |
| CN111566125A (zh) * | 2017-09-11 | 2020-08-21 | 特韦斯特生物科学公司 | Gpcr结合蛋白及其合成 |
| BR112020005212A2 (pt) | 2017-09-18 | 2020-09-15 | Sutro Biopharma, Inc. | conjugado de anticorpo, kit, composição farmacêutica, e, métodos de tratamento ou prevenção e de diagnóstico de uma doença ou condição. |
| EP3694545A4 (en) | 2017-10-11 | 2021-12-01 | Board Of Regents, The University Of Texas System | HUMAN PD-L1 ANTIBODIES AND METHOD OF USING THEM |
| WO2019089753A2 (en) | 2017-10-31 | 2019-05-09 | Compass Therapeutics Llc | Cd137 antibodies and pd-1 antagonists and uses thereof |
| WO2019099454A2 (en) * | 2017-11-15 | 2019-05-23 | Philippe Valadon | Highly functional antibody libraries |
| TWI816715B (zh) | 2017-11-17 | 2023-10-01 | 美商默沙東有限責任公司 | 對免疫球蛋白樣轉錄本3(ilt3)具特異性之抗體及其用途 |
| US11851497B2 (en) | 2017-11-20 | 2023-12-26 | Compass Therapeutics Llc | CD137 antibodies and tumor antigen-targeting antibodies and uses thereof |
| AU2018371271A1 (en) | 2017-11-27 | 2020-06-11 | Purdue Pharma L.P. | Humanized antibodies targeting human tissue factor |
| WO2019129137A1 (zh) | 2017-12-27 | 2019-07-04 | 信达生物制药(苏州)有限公司 | 抗lag-3抗体及其用途 |
| CN109970856B (zh) | 2017-12-27 | 2022-08-23 | 信达生物制药(苏州)有限公司 | 抗lag-3抗体及其用途 |
| EP3735271A4 (en) | 2018-01-04 | 2022-06-15 | Iconic Therapeutics, Inc. | ANTI-TISSUE FACTOR ANTIBODIES, ANTIBODY DRUG CONJUGATES AND RELATED METHODS |
| CN116041516A (zh) | 2018-02-01 | 2023-05-02 | 信达生物制药(苏州)有限公司 | 全人源的抗b细胞成熟抗原(bcma)单链抗体及其应用 |
| US11884733B2 (en) | 2018-02-08 | 2024-01-30 | Dragonfly Therapeutics, Inc. | Antibody variable domains targeting the NKG2D receptor |
| CA3091801A1 (en) | 2018-03-02 | 2019-09-06 | Five Prime Therapeutics, Inc. | B7-h4 antibodies and methods of use thereof |
| JP7037218B2 (ja) | 2018-03-14 | 2022-03-16 | サーフィス オンコロジー インコーポレイテッド | Ｃｄ３９と結合する抗体及びその使用 |
| CN112512571A (zh) | 2018-03-22 | 2021-03-16 | 表面肿瘤学公司 | 抗il-27抗体及其用途 |
| US20210214445A1 (en) | 2018-03-23 | 2021-07-15 | Board Of Regents, The University Of Texas System | Dual specificity antibodies to pd-l1 and pd-l2 and methods of use therefor |
| US11993658B2 (en) | 2018-03-26 | 2024-05-28 | Sutro Biopharma, Inc. | Anti-BCMA antibodies and treatment methods |
| CN110464842B (zh) | 2018-05-11 | 2022-10-14 | 信达生物制药(苏州)有限公司 | 包含抗pcsk9抗体的制剂及其用途 |
| CN112533945A (zh) * | 2018-05-18 | 2021-03-19 | 宏观基因有限公司 | 优化的结合gp41的分子及其用途 |
| SG11202011082UA (en) | 2018-05-25 | 2020-12-30 | Alector Llc | Anti-sirpa antibodies and methods of use thereof |
| WO2019232244A2 (en) | 2018-05-31 | 2019-12-05 | Novartis Ag | Antibody molecules to cd73 and uses thereof |
| KR102115300B1 (ko) * | 2018-06-01 | 2020-05-26 | 재단법인 목암생명과학연구소 | 항체 라이브러리 및 이를 이용한 항체 스크리닝 방법 |
| EP3814376A4 (en) | 2018-06-26 | 2022-07-06 | Mor Research Applications Ltd. | ANTI-TRANSTHYRETIN ANTIBODIES AND THEIR USES |
| WO2020006374A2 (en) | 2018-06-29 | 2020-01-02 | Alector Llc | Anti-sirp-beta1 antibodies and methods of use thereof |
| EP3833685A4 (en) | 2018-07-08 | 2022-08-17 | Specifica Inc. | ANTIBODY LIBRARIES WITH FEATURES FOR MAXIMIZED ANTIBODY DEVELOPMENT |
| TWI809147B (zh) | 2018-07-13 | 2023-07-21 | 美商阿列克特有限責任公司 | 抗分揀蛋白抗體及其使用方法 |
| BR112021000727A2 (pt) | 2018-07-20 | 2021-04-13 | Surface Oncology, Inc. | Composições anti-cd112r e métodos |
| JP7524065B2 (ja) | 2018-07-25 | 2024-07-29 | イノベント バイオロジックス （スウツォウ） カンパニー，リミテッド | 抗ｔｉｇｉｔ抗体及びその使用 |
| CN112752768A (zh) | 2018-07-27 | 2021-05-04 | 艾利妥 | 抗siglec-5抗体及其使用方法 |
| WO2020033925A2 (en) | 2018-08-09 | 2020-02-13 | Compass Therapeutics Llc | Antibodies that bind cd277 and uses thereof |
| US20210309746A1 (en) | 2018-08-09 | 2021-10-07 | Compass Therapeutics Llc | Antibodies that bind cd277 and uses thereof |
| EP3833443A1 (en) | 2018-08-09 | 2021-06-16 | Compass Therapeutics LLC | Antigen binding agents that bind cd277 and uses thereof |
| EP3841123A2 (en) | 2018-08-23 | 2021-06-30 | Seagen Inc. | Anti-tigit antibodies |
| EP3852811A1 (en) | 2018-09-17 | 2021-07-28 | Sutro Biopharma, Inc. | Combination therapies with anti-folate receptor antibody conjugates |
| CA3114407A1 (en) | 2018-09-27 | 2020-04-02 | Tizona Therapeutics | Anti-hla-g antibodies, compositions comprising anti-hla-g antibodies and methods of using anti-hla-g antibodies |
| US11046769B2 (en) | 2018-11-13 | 2021-06-29 | Compass Therapeutics Llc | Multispecific binding constructs against checkpoint molecules and uses thereof |
| AU2020206588A1 (en) | 2019-01-07 | 2021-08-19 | iTeos Belgium SA | Anti-tigit antibodies |
| CN113474371A (zh) | 2019-01-16 | 2021-10-01 | 指南针制药有限责任公司 | 与人cd137结合的抗体的制剂及其用途 |
| BR112021016537A2 (pt) | 2019-02-21 | 2021-10-26 | Trishula Therapeutics, Inc. | Terapia de combinação envolvendo anticorpos anti-cd39 e anticorpos anti-pd-1 ou anti-pd-l1 |
| KR20210144698A (ko) * | 2019-02-26 | 2021-11-30 | 트위스트 바이오사이언스 코포레이션 | 항체 최적화를 위한 변이 핵산 라이브러리 |
| PE20212265A1 (es) | 2019-03-18 | 2021-11-30 | Janssen Pharmaceuticals Inc | Bioconjugados de antigenos-polisacaridos de e. coli, metodos de produccion y metodos de utilizacion de los mismos |
| KR20220005471A (ko) | 2019-04-08 | 2022-01-13 | 바이오젠 엠에이 인코포레이티드 | 항-인테그린 항체 및 이의 용도 |
| US20220362394A1 (en) | 2019-05-03 | 2022-11-17 | Sutro Biopharma, Inc. | Anti-bcma antibody conjugates |
| AU2020270407A1 (en) | 2019-05-03 | 2021-12-02 | Celgene Corporation | Anti-BCMA antibody conjugate, compositions comprising the same, and methods of making and using the same |
| EP3980423A1 (en) | 2019-06-10 | 2022-04-13 | Sutro Biopharma, Inc. | 5h-pyrrolo[3,2-d]pyrimidine-2,4-diamino compounds and antibody conjugates thereof |
| US20220259202A1 (en) | 2019-06-17 | 2022-08-18 | Sutro Biopharma, Inc. | 1-(4-(aminomethyl)benzyl)-2-butyl-2h-pyrazolo[3,4-c]quinolin-4-amine derivatives and related compounds as toll-like receptor (tlr) 7/8 agonists, as well as antibody drug conjugates thereof for use in cancer therapy and diagnosis |
| WO2021055329A1 (en) | 2019-09-16 | 2021-03-25 | Surface Oncology, Inc. | Anti-cd39 antibody compositions and methods |
| CN115087671A (zh) | 2019-09-25 | 2022-09-20 | 表面肿瘤学公司 | 抗il-27抗体及其用途 |
| WO2021080682A1 (en) | 2019-10-24 | 2021-04-29 | Massachusetts Institute Of Technology | Monoclonal antibodies that bind human cd161 and uses thereof |
| EP3986937A1 (en) | 2019-12-05 | 2022-04-27 | Alector LLC | Methods of use of anti-trem2 antibodies |
| CN115066437A (zh) | 2019-12-12 | 2022-09-16 | 艾利妥 | 使用抗cd33抗体的方法 |
| US20230027822A1 (en) * | 2019-12-13 | 2023-01-26 | Nanjing GenScript Biotech Co., Ltd. | Method for Constructing Antibody Complementarity Determining Region Library |
| EP4089114A1 (en) | 2020-01-09 | 2022-11-16 | Innovent Biologics (Suzhou) Co., Ltd. | Application of combination of anti-cd47 antibody and anti-cd20 antibody in preparation of drugs for preventing or treating tumors |
| CN111139264B (zh) * | 2020-01-20 | 2021-07-06 | 天津达济科技有限公司 | 一种基于线性双链dna分子在哺乳动物细胞系内构建单域抗体库的方法 |
| IL295188A (en) | 2020-02-18 | 2022-09-01 | Alector Llc | pilra antibodies and methods of using them |
| CN115768794A (zh) | 2020-02-24 | 2023-03-07 | 艾利妥 | 抗trem2抗体的使用方法 |
| CA3173521A1 (en) * | 2020-02-28 | 2021-09-02 | The Brigham And Women's Hospital, Inc. | Selective modulation of transforming growth factor beta superfamily signaling via multi-specific antibodies |
| US20230139700A1 (en) | 2020-03-23 | 2023-05-04 | Bio-Thera Solutions, Ltd. | Development and application of immune cell activator |
| EP4126953A2 (en) | 2020-04-03 | 2023-02-08 | Alector LLC | Methods of use of anti-trem2 antibodies |
| KR20230005268A (ko) | 2020-04-24 | 2023-01-09 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | 항-cd19 항체 및 이의 용도 |
| CA3182150A1 (en) | 2020-05-17 | 2021-11-25 | Astrazeneca Uk Limited | Sars-cov-2 antibodies and methods of selecting and using the same |
| EP4169948A4 (en) | 2020-06-22 | 2024-07-10 | Innovent Biologics Suzhou Co Ltd | ANTI-CD73 ANTIBODIES AND USE THEREOF |
| EP4168115A1 (en) | 2020-06-22 | 2023-04-26 | The Board of Trustees of the Leland Stanford Junior University | Tsp-1 inhibitors for the treatment of aged, atrophied or dystrophied muscle |
| BR112023000603A2 (pt) | 2020-07-20 | 2023-01-31 | Astrazeneca Uk Ltd | Proteínas sars-cov-2, anticorpos anti-sars-cov-2 e métodos de uso dos mesmos |
| TW202227489A (zh) | 2020-08-18 | 2022-07-16 | 美商希佛隆公司 | 抗par-2抗體及其使用方法 |
| KR20230104659A (ko) | 2020-11-08 | 2023-07-10 | 씨젠 인크. | 면역 세포 억제제를 이용한 조합-요법 항체 약물 접합체 |
| EP4256116A1 (en) | 2020-12-03 | 2023-10-11 | Tavotek Biotherapeutics (Hong Kong) Limited | Variable heavy chain only libraries, methods of preparation thereof, and uses thereof |
| AU2021396381A1 (en) | 2020-12-11 | 2023-07-06 | The University Of North Carolina At Chapel Hill | Compositions and methods comprising sfrp2 antagonists |
| JP2024505049A (ja) | 2021-01-29 | 2024-02-02 | ノバルティス アーゲー | 抗ｃｄ７３及び抗ｅｎｔｐｄ２抗体のための投与方式並びにその使用 |
| CA3216170A1 (en) | 2021-04-09 | 2022-10-13 | Seagen Inc. | Methods of treating cancer with anti-tigit antibodies |
| AR125490A1 (es) | 2021-04-30 | 2023-07-19 | Celgene Corp | Terapias de combinación que utilizan un anticuerpo anti-bcma conjugado a fármaco (adc) en combinación con un inhibidor de gamma secretasa (gsi) |
| EP4340876A1 (en) | 2021-05-19 | 2024-03-27 | Sutro Biopharma, Inc. | Anti-folate receptor conjugate combination therapy with bevacizumab |
| CN113668068B (zh) * | 2021-07-20 | 2024-07-19 | 广州滴纳生物科技有限公司 | 基因组甲基化文库及其制备方法和应用 |
| JP2024533993A (ja) | 2021-08-09 | 2024-09-18 | 普米斯生物技術（珠海）有限公司 | 抗ｔｉｇｉｔ抗体およびその使用 |
| EP4384545A1 (en) | 2021-08-10 | 2024-06-19 | BYOMass Inc. | Anti-gdf15 antibodies, compositions and uses thereof |
| CA3229448A1 (en) | 2021-08-23 | 2023-03-02 | Immunitas Therapeutics, Inc. | Anti-cd161 antibodies and uses thereof |
| CN118451101A (zh) | 2021-10-18 | 2024-08-06 | 百欧麦斯公司 | 抗激活素a抗体、组合物及其用途 |
| WO2023081898A1 (en) | 2021-11-08 | 2023-05-11 | Alector Llc | Soluble cd33 as a biomarker for anti-cd33 efficacy |
| KR20240108799A (ko) | 2021-12-01 | 2024-07-09 | 서트로 바이오파마, 인크. | 항 엽산 수용체 접합체 암 요법 |
| WO2023104904A2 (en) | 2021-12-08 | 2023-06-15 | Genclis | The sars-cov-2 and variants use two independent cell receptors to replicate |
| WO2023122213A1 (en) | 2021-12-22 | 2023-06-29 | Byomass Inc. | Targeting gdf15-gfral pathway cross-reference to related applications |
| WO2023147107A1 (en) | 2022-01-31 | 2023-08-03 | Byomass Inc. | Myeloproliferative conditions |
| TW202342510A (zh) | 2022-02-18 | 2023-11-01 | 英商Ｒｑ生物科技有限公司 | 抗體 |
| CN118765204A (zh) | 2022-02-23 | 2024-10-11 | 艾利妥 | 抗trem2抗体的使用方法 |
| WO2023178192A1 (en) | 2022-03-15 | 2023-09-21 | Compugen Ltd. | Il-18bp antagonist antibodies and their use in monotherapy and combination therapy in the treatment of cancer |
| WO2023192976A1 (en) | 2022-04-01 | 2023-10-05 | Board Of Regents, The University Of Texas System | Dual specificity antibodies to human pd-l1 and pd-l2 and methods of use therefor |
| WO2023209177A1 (en) | 2022-04-29 | 2023-11-02 | Astrazeneca Uk Limited | Sars-cov-2 antibodies and methods of using the same |
| WO2024102948A1 (en) | 2022-11-11 | 2024-05-16 | Celgene Corporation | Fc receptor-homolog 5 (fcrh5) specific binding molecules and bispecific t-cell engaging antibodies including same and related methods |
| WO2024191807A1 (en) | 2023-03-10 | 2024-09-19 | Seagen Inc. | Methods of treating cancer with anti-tigit antibodies |
Family Cites Families (220)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4230685A (en) | 1979-02-28 | 1980-10-28 | Northwestern University | Method of magnetic separation of cells and the like, and microspheres for use therein |
| US4452773A (en) | 1982-04-05 | 1984-06-05 | Canadian Patents And Development Limited | Magnetic iron-dextran microspheres |
| US4661454A (en) | 1983-02-28 | 1987-04-28 | Collaborative Research, Inc. | GAL1 yeast promoter linked to non galactokinase gene |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| GB8408127D0 (en) | 1984-03-29 | 1984-05-10 | Nyegaard & Co As | Contrast agents |
| US5118605A (en) | 1984-10-16 | 1992-06-02 | Chiron Corporation | Polynucleotide determination with selectable cleavage sites |
| DE3590766T (da) | 1985-03-30 | 1987-04-23 | ||
| US6492107B1 (en) | 1986-11-20 | 2002-12-10 | Stuart Kauffman | Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique |
| CA1293460C (en) | 1985-10-07 | 1991-12-24 | Brian Lee Sauer | Site-specific recombination of dna in yeast |
| US5618920A (en) | 1985-11-01 | 1997-04-08 | Xoma Corporation | Modular assembly of antibody genes, antibodies prepared thereby and use |
| US4770183A (en) | 1986-07-03 | 1988-09-13 | Advanced Magnetics Incorporated | Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| ATE87659T1 (de) | 1986-09-02 | 1993-04-15 | Enzon Lab Inc | Bindungsmolekuele mit einzelpolypeptidkette. |
| ATE114723T1 (de) | 1987-03-02 | 1994-12-15 | Enzon Lab Inc | Organismus als träger für ''single chain antibody domain (scad)''. |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5750373A (en) | 1990-12-03 | 1998-05-12 | Genentech, Inc. | Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants |
| US5688666A (en) | 1988-10-28 | 1997-11-18 | Genentech, Inc. | Growth hormone variants with altered binding properties |
| KR0184860B1 (ko) | 1988-11-11 | 1999-04-01 | 메디칼 리써어치 카운실 | 단일영역 리간드와 이를 포함하는 수용체 및 이들의 제조방법과 이용(법) |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| DE68919715T2 (de) | 1988-12-28 | 1995-04-06 | Stefan Miltenyi | Verfahren sowie materialien zur hochgraduierten magnetischen abspaltung biologischer materialien. |
| US6969586B1 (en) | 1989-05-16 | 2005-11-29 | Scripps Research Institute | Method for tapping the immunological repertoire |
| US6291160B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for producing polymers having a preselected activity |
| US6291161B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for tapping the immunological repertiore |
| US6680192B1 (en) | 1989-05-16 | 2004-01-20 | Scripps Research Institute | Method for producing polymers having a preselected activity |
| US6291159B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for producing polymers having a preselected activity |
| US6291158B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for tapping the immunological repertoire |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| US5283173A (en) | 1990-01-24 | 1994-02-01 | The Research Foundation Of State University Of New York | System to detect protein-protein interactions |
| DE4002897A1 (de) | 1990-02-01 | 1991-08-08 | Behringwerke Ag | Herstellung und verwendung von genbanken synthetischer menschlicher antikoerper ("synthetische human-antikoerper-bibliotheken") |
| DK0440147T3 (da) | 1990-02-01 | 2005-01-17 | Dade Behring Marburg Gmbh | Fremstilling og anvendelse af genbanker af humant antistof ("humant-antistof-biblioteker") |
| ES2078518T3 (es) | 1990-04-05 | 1995-12-16 | Roberto Crea | Mutagenesis por desplazamiento completo. |
| ATE167520T1 (de) | 1990-04-18 | 1998-07-15 | Gist Brocades Nv | Mutierte beta-lactamacylasegene |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| GB9206318D0 (en) | 1992-03-24 | 1992-05-06 | Cambridge Antibody Tech | Binding substances |
| US6172197B1 (en) | 1991-07-10 | 2001-01-09 | Medical Research Council | Methods for producing members of specific binding pairs |
| US7063943B1 (en) | 1990-07-10 | 2006-06-20 | Cambridge Antibody Technology | Methods for producing members of specific binding pairs |
| US6916605B1 (en) | 1990-07-10 | 2005-07-12 | Medical Research Council | Methods for producing members of specific binding pairs |
| US5780279A (en) | 1990-12-03 | 1998-07-14 | Genentech, Inc. | Method of selection of proteolytic cleavage sites by directed evolution and phagemid display |
| WO1992018619A1 (en) | 1991-04-10 | 1992-10-29 | The Scripps Research Institute | Heterodimeric receptor libraries using phagemids |
| US6072039A (en) | 1991-04-19 | 2000-06-06 | Rohm And Haas Company | Hybrid polypeptide comparing a biotinylated avidin binding polypeptide fused to a polypeptide of interest |
| US6225447B1 (en) | 1991-05-15 | 2001-05-01 | Cambridge Antibody Technology Ltd. | Methods for producing members of specific binding pairs |
| US5962255A (en) | 1992-03-24 | 1999-10-05 | Cambridge Antibody Technology Limited | Methods for producing recombinant vectors |
| US5858657A (en) | 1992-05-15 | 1999-01-12 | Medical Research Council | Methods for producing members of specific binding pairs |
| US6492160B1 (en) | 1991-05-15 | 2002-12-10 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| US5871907A (en) | 1991-05-15 | 1999-02-16 | Medical Research Council | Methods for producing members of specific binding pairs |
| DE69228247T2 (de) | 1991-08-10 | 1999-07-08 | Medical Research Council, London | Behandlung von Zellpopulationen |
| US5565332A (en) | 1991-09-23 | 1996-10-15 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
| US5665563A (en) | 1991-10-11 | 1997-09-09 | Promega Corporation | Coupled transcription and translation in eukaryotic cell-free extract |
| WO1993007287A1 (en) | 1991-10-11 | 1993-04-15 | Promega Corporation | Coupled transcription and translation in eukaryotic cell-free extract |
| US5492817A (en) | 1993-11-09 | 1996-02-20 | Promega Corporation | Coupled transcription and translation in eukaryotic cell-free extract |
| US5866344A (en) | 1991-11-15 | 1999-02-02 | Board Of Regents, The University Of Texas System | Antibody selection methods using cell surface expressed libraries |
| US20030036092A1 (en) | 1991-11-15 | 2003-02-20 | Board Of Regents, The University Of Texas System | Directed evolution of enzymes and antibodies |
| EP0617706B1 (en) | 1991-11-25 | 2001-10-17 | Enzon, Inc. | Multivalent antigen-binding proteins |
| US5872215A (en) | 1991-12-02 | 1999-02-16 | Medical Research Council | Specific binding members, materials and methods |
| ES2227512T3 (es) | 1991-12-02 | 2005-04-01 | Medical Research Council | Produccion de anticuerpos contra auto-antigenos a partir de repertorios de segmentos de anticuerpos fijados en un fago. |
| US5667988A (en) * | 1992-01-27 | 1997-09-16 | The Scripps Research Institute | Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| US5733743A (en) | 1992-03-24 | 1998-03-31 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| ES2196009T3 (es) | 1992-07-08 | 2003-12-16 | Unilever Nv | Procedimiento para inmovilizar enzimas en la pared celular de una celula microbiana mediante la produccion de una proteina de fusion. |
| ATE348175T1 (de) | 1992-07-17 | 2007-01-15 | Dana Farber Cancer Inst Inc | Method eder intrazellularen bindung von zielgerichteten molekülen |
| AU681360B2 (en) | 1992-09-30 | 1997-08-28 | Scripps Research Institute, The | Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| US7166423B1 (en) | 1992-10-21 | 2007-01-23 | Miltenyi Biotec Gmbh | Direct selection of cells by secretion product |
| DE4237113B4 (de) | 1992-11-03 | 2006-10-12 | "Iba Gmbh" | Peptide und deren Fusionsproteine, Expressionsvektor und Verfahren zur Herstellung eines Fusionsproteins |
| DK0672142T3 (da) | 1992-12-04 | 2001-06-18 | Medical Res Council | Multivalente og multispecifikke bindingsproteiner samt fremstilling og anvendelse af disse |
| GB9225453D0 (en) | 1992-12-04 | 1993-01-27 | Medical Res Council | Binding proteins |
| CA2155335C (en) | 1993-02-04 | 2001-06-05 | HANS CHRISTIAN THõGERSEN | Improved method for the refolding of proteins |
| DK0682710T3 (da) | 1993-02-10 | 2004-03-01 | Unilever Nv | Isolationsmetode, ved hvilken der anvendes immobiliserede proteiner med specifikke kapaciteter |
| GB9313509D0 (en) | 1993-06-30 | 1993-08-11 | Medical Res Council | Chemisynthetic libraries |
| US5874239A (en) | 1993-07-30 | 1999-02-23 | Affymax Technologies N.V. | Biotinylation of proteins |
| AU680685B2 (en) | 1993-09-22 | 1997-08-07 | Medical Research Council | Retargeting antibodies |
| US5922545A (en) | 1993-10-29 | 1999-07-13 | Affymax Technologies N.V. | In vitro peptide and antibody display libraries |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US5525490A (en) | 1994-03-29 | 1996-06-11 | Onyx Pharmaceuticals, Inc. | Reverse two-hybrid method |
| US5695941A (en) | 1994-06-22 | 1997-12-09 | The General Hospital Corporation | Interaction trap systems for analysis of protein networks |
| CU22615A1 (es) | 1994-06-30 | 2000-02-10 | Centro Inmunologia Molecular | Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos |
| GB9414506D0 (en) * | 1994-07-18 | 1994-09-07 | Zeneca Ltd | Improved production of polyhydroxyalkanoate |
| US5888773A (en) | 1994-08-17 | 1999-03-30 | The United States Of America As Represented By The Department Of Health And Human Services | Method of producing single-chain Fv molecules |
| US5763733A (en) | 1994-10-13 | 1998-06-09 | Enzon, Inc. | Antigen-binding fusion proteins |
| GB9504344D0 (en) | 1995-03-03 | 1995-04-19 | Unilever Plc | Antibody fragment production |
| DE69636866D1 (en) | 1995-04-11 | 2007-03-15 | Gen Hospital Corp | Reverse "two-hybrid"-systeme |
| US7264963B1 (en) | 1995-08-18 | 2007-09-04 | Morphosys Ag | Protein(poly)peptide libraries |
| WO1997008320A1 (en) | 1995-08-18 | 1997-03-06 | Morphosys Gesellschaft Für Proteinoptimierung Mbh | Protein/(poly)peptide libraries |
| FR2741892B1 (fr) | 1995-12-04 | 1998-02-13 | Pasteur Merieux Serums Vacc | Procede de preparation d'une banque multicombinatoire de vecteurs d'expression de genes d'anticorps, banque et systemes d'expression d'anticorps "coliclonaux" obtenus |
| DE19637718A1 (de) | 1996-04-01 | 1997-10-02 | Boehringer Mannheim Gmbh | Rekombinante inaktive Core-Streptavidin Mutanten |
| JP2000508923A (ja) | 1996-04-26 | 2000-07-18 | マサチューセッツ・インスティテュート・オブ・テクノロジー | ３―ハイブリッド・スクリーニング・アッセイ |
| US6696251B1 (en) | 1996-05-31 | 2004-02-24 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
| US6300065B1 (en) | 1996-05-31 | 2001-10-09 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
| US6699658B1 (en) | 1996-05-31 | 2004-03-02 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
| US6083693A (en) | 1996-06-14 | 2000-07-04 | Curagen Corporation | Identification and comparison of protein-protein interactions that occur in populations |
| DE19624562A1 (de) | 1996-06-20 | 1998-01-02 | Thomas Dr Koehler | Verfahren zur Bestimmung von Konzentrationsverhältnissen zweier sich um mindestens ein Nucleotid unterscheidender Nucleinsäuren und Testkit zur Durchführung des Verfahrens |
| ES2224255T3 (es) | 1996-06-24 | 2005-03-01 | Zlb Behring Ag | Polipeptidos capaces de formar estructuras de union a antigenos con especificidad por los antigenos de rhesus d, el dna que los codifica y el proceso para su preparacion y uso. |
| US5994515A (en) | 1996-06-25 | 1999-11-30 | Trustees Of The University Of Pennsylvania | Antibodies directed against cellular coreceptors for human immunodeficiency virus and methods of using the same |
| GB9712818D0 (en) | 1996-07-08 | 1997-08-20 | Cambridge Antibody Tech | Labelling and selection of specific binding molecules |
| US5948620A (en) | 1996-08-05 | 1999-09-07 | Amersham International Plc | Reverse two-hybrid system employing post-translation signal modulation |
| US5955275A (en) | 1997-02-14 | 1999-09-21 | Arcaris, Inc. | Methods for identifying nucleic acid sequences encoding agents that affect cellular phenotypes |
| US5925523A (en) | 1996-08-23 | 1999-07-20 | President & Fellows Of Harvard College | Intraction trap assay, reagents and uses thereof |
| JP2001501097A (ja) | 1996-09-24 | 2001-01-30 | ケイダス ファーマスーティカル コーポレイション | レセプターエフェクターを同定する方法及び組成物 |
| DE19641876B4 (de) | 1996-10-10 | 2011-09-29 | Iba Gmbh | Streptavidinmuteine |
| US6255455B1 (en) | 1996-10-11 | 2001-07-03 | The Trustees Of The University Of Pennsylvania | Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof |
| US5858671A (en) | 1996-11-01 | 1999-01-12 | The University Of Iowa Research Foundation | Iterative and regenerative DNA sequencing method |
| US5869250A (en) | 1996-12-02 | 1999-02-09 | The University Of North Carolina At Chapel Hill | Method for the identification of peptides that recognize specific DNA sequences |
| JP3692542B2 (ja) | 1997-01-21 | 2005-09-07 | ザ ジェネラル ホスピタル コーポレーション | Ｒｎａ−蛋白質の融合体を用いた蛋白質の選抜 |
| US6261804B1 (en) | 1997-01-21 | 2001-07-17 | The General Hospital Corporation | Selection of proteins using RNA-protein fusions |
| WO1998040396A1 (en) | 1997-03-14 | 1998-09-17 | Trustees Of Boston University | Multiflavor streptavidin |
| US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
| EP0985033A4 (en) | 1997-04-04 | 2005-07-13 | Biosite Inc | POLYVALENT AND POLYCLONAL LIBRARIES |
| JP4086325B2 (ja) | 1997-04-23 | 2008-05-14 | プリュックテュン，アンドレアス | 標的分子と相互作用する（ポリ）ペプチドをコードする核酸分子の同定方法 |
| AU7266698A (en) | 1997-04-30 | 1998-11-24 | Enzon, Inc. | Polyalkylene oxide-modified single chain polypeptides |
| GB2339430A (en) | 1997-05-21 | 2000-01-26 | Biovation Ltd | Method for the production of non-immunogenic proteins |
| WO1999006834A2 (en) | 1997-08-04 | 1999-02-11 | Ixsys, Incorporated | Methods for identifying ligand specific binding molecules |
| US6391311B1 (en) | 1998-03-17 | 2002-05-21 | Genentech, Inc. | Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1 |
| GB9722131D0 (en) | 1997-10-20 | 1997-12-17 | Medical Res Council | Method |
| ATE269974T1 (de) | 1997-11-27 | 2004-07-15 | Max Planck Gesellschaft | Identifizierung und charakterisierung von interagierenden molekülen mittels automatisierter interagierender paarung |
| WO1999028502A1 (en) | 1997-11-28 | 1999-06-10 | Invitrogen Corporation | Single chain monoclonal antibody fusion reagents that regulate transcription in vivo |
| US6759243B2 (en) | 1998-01-20 | 2004-07-06 | Board Of Trustees Of The University Of Illinois | High affinity TCR proteins and methods |
| WO1999039744A1 (en) | 1998-02-10 | 1999-08-12 | The Ohio State University Research Foundation | Compositions and methods for polynucleotide delivery |
| US6187535B1 (en) | 1998-02-18 | 2001-02-13 | Institut Pasteur | Fast and exhaustive method for selecting a prey polypeptide interacting with a bait polypeptide of interest: application to the construction of maps of interactors polypeptides |
| NZ507161A (en) | 1998-03-30 | 2003-12-19 | Northwest Biotherapeutics Inc | Theraupeutic and diagonistic applications based on the role of the CXCR-4 gene in tumorigenesis |
| US20020029391A1 (en) | 1998-04-15 | 2002-03-07 | Claude Geoffrey Davis | Epitope-driven human antibody production and gene expression profiling |
| US7244826B1 (en) | 1998-04-24 | 2007-07-17 | The Regents Of The University Of California | Internalizing ERB2 antibodies |
| WO2000018905A1 (en) | 1998-09-25 | 2000-04-06 | G.D. Searle & Co. | Method of producing permuteins by scanning permutagenesis |
| GB2344886B (en) | 1999-03-10 | 2000-11-01 | Medical Res Council | Selection of intracellular immunoglobulins |
| US6531580B1 (en) | 1999-06-24 | 2003-03-11 | Ixsys, Inc. | Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same |
| IL142025A0 (en) | 1999-07-20 | 2002-03-10 | Morphosys Ag | Novel methods for displaying (poly) peptides/proteins on bacteriophage particles via disulfide bonds |
| US6171795B1 (en) | 1999-07-29 | 2001-01-09 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands to CD40ligand |
| US7037706B1 (en) | 1999-09-29 | 2006-05-02 | Xenoport, Inc. | Compounds displayed on replicable genetic packages and methods of using same |
| EP1224327A4 (en) | 1999-09-29 | 2004-09-08 | Xenoport Inc | COMPOSITIONS ON GENETICALLY REPLICABLE PRODUCTS AND METHODS FOR THEIR USE |
| WO2001079229A2 (en) | 2000-04-13 | 2001-10-25 | Genaissance Pharmaceuticals, Inc. | Haplotypes of the cxcr4 gene |
| JP5149476B2 (ja) | 2000-04-17 | 2013-02-20 | ダイアックス コーポレイション | ペプチドの多種多様なファミリーのメンバーとしての、遺伝的パッケージの提示ライブラリーを構築する方法 |
| US8288322B2 (en) | 2000-04-17 | 2012-10-16 | Dyax Corp. | Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries |
| US6358733B1 (en) | 2000-05-19 | 2002-03-19 | Apolife, Inc. | Expression of heterologous multi-domain proteins in yeast |
| US20050158838A1 (en) | 2000-06-19 | 2005-07-21 | Dyax Corp., A Delaware Corporation | Novel enterokinase cleavage sequences |
| US6410246B1 (en) | 2000-06-23 | 2002-06-25 | Genetastix Corporation | Highly diverse library of yeast expression vectors |
| US6410271B1 (en) | 2000-06-23 | 2002-06-25 | Genetastix Corporation | Generation of highly diverse library of expression vectors via homologous recombination in yeast |
| US6406863B1 (en) | 2000-06-23 | 2002-06-18 | Genetastix Corporation | High throughput generation and screening of fully human antibody repertoire in yeast |
| AU2001273287A1 (en) | 2000-07-13 | 2002-01-30 | The Curators Of The University Of Missouri | Large scale expression and purification of recombinant proteins |
| US6512263B1 (en) | 2000-09-22 | 2003-01-28 | Sandisk Corporation | Non-volatile memory cell array having discontinuous source and drain diffusions contacted by continuous bit line conductors and methods of forming |
| US6750042B2 (en) | 2000-10-12 | 2004-06-15 | University Of Georgia Research Foundation, Inc. | Metal binding proteins, recombinant host cells and methods |
| US7083945B1 (en) | 2000-10-27 | 2006-08-01 | The Board Of Regents Of The University Of Texas System | Isolation of binding proteins with high affinity to ligands |
| US7094571B2 (en) | 2000-10-27 | 2006-08-22 | The Board Of Regents Of The University Of Texas System | Combinatorial protein library screening by periplasmic expression |
| US7138496B2 (en) | 2002-02-08 | 2006-11-21 | Genetastix Corporation | Human monoclonal antibodies against human CXCR4 |
| US20030165988A1 (en) | 2002-02-08 | 2003-09-04 | Shaobing Hua | High throughput generation of human monoclonal antibody against peptide fragments derived from membrane proteins |
| US6841359B2 (en) | 2000-10-31 | 2005-01-11 | The General Hospital Corporation | Streptavidin-binding peptides and uses thereof |
| US6610472B1 (en) | 2000-10-31 | 2003-08-26 | Genetastix Corporation | Assembly and screening of highly complex and fully human antibody repertoire in yeast |
| US7005503B2 (en) | 2002-02-08 | 2006-02-28 | Genetastix Corporation | Human monoclonal antibody against coreceptors for human immunodeficiency virus |
| EP1360288B1 (en) | 2000-12-18 | 2011-02-16 | Dyax Corp. | Focused libraries of genetic packages |
| EP1227321A1 (en) | 2000-12-28 | 2002-07-31 | Institut für Bioanalytik GmbH | Reversible MHC multimer staining for functional purification of antigen-specific T cells |
| US20020197691A1 (en) | 2001-04-30 | 2002-12-26 | Myriad Genetics, Incorporated | FLT4-interacting proteins and use thereof |
| CA2434802C (en) | 2001-01-16 | 2013-05-28 | Regeneron Pharmaceuticals, Inc. | Isolating cells expressing secreted proteins |
| WO2002077182A2 (en) | 2001-03-21 | 2002-10-03 | Xenoport, Inc. | Compounds displayed on icosahedral phage and methods of using same |
| DE10113776B4 (de) | 2001-03-21 | 2012-08-09 | "Iba Gmbh" | Isoliertes streptavidinbindendes, kompetitiv eluierbares Peptid, dieses umfassendes Fusionspeptid, dafür codierende Nukleinsäure, Expressionsvektor, Verfahren zur Herstellung eines rekombinanten Fusionsproteins und Verfahren zum Nachweis und/oder zur Gewinnung des Fusionsproteins |
| WO2002081683A2 (en) | 2001-04-05 | 2002-10-17 | Nextgen Sciences Ltd. | Protein analysis by means of immobilized arrays of antigens or antibodies |
| AU2002307229B2 (en) | 2001-04-06 | 2007-05-24 | Thomas Jefferson University | Multimerization of HIV-1 Vif protein as a therapeutic target |
| US20040175756A1 (en) | 2001-04-26 | 2004-09-09 | Avidia Research Institute | Methods for using combinatorial libraries of monomer domains |
| US20050089932A1 (en) | 2001-04-26 | 2005-04-28 | Avidia Research Institute | Novel proteins with targeted binding |
| US20050053973A1 (en) | 2001-04-26 | 2005-03-10 | Avidia Research Institute | Novel proteins with targeted binding |
| US20050048512A1 (en) | 2001-04-26 | 2005-03-03 | Avidia Research Institute | Combinatorial libraries of monomer domains |
| ATE472609T1 (de) | 2001-04-26 | 2010-07-15 | Amgen Mountain View Inc | Kombinatorische bibliotheken von monomerdomänen |
| DE10129815A1 (de) | 2001-06-24 | 2003-01-09 | Profos Ag | Verfahren zur Aufreinigung von Bakterienzellen und Zellbestandteilen |
| GB0118337D0 (en) | 2001-07-27 | 2001-09-19 | Lonza Biologics Plc | Method for selecting antibody expressing cells |
| US6833441B2 (en) | 2001-08-01 | 2004-12-21 | Abmaxis, Inc. | Compositions and methods for generating chimeric heteromultimers |
| EP1433793A4 (en) | 2001-09-13 | 2006-01-25 | Inst Antibodies Co Ltd | METHOD FOR CREATING A CAMEL ANTIBODY LIBRARY |
| US20030092073A1 (en) | 2001-09-25 | 2003-05-15 | Dorothee Ambrosius | Method for sequence specific biotinylation |
| WO2003029471A1 (en) | 2001-09-27 | 2003-04-10 | Pieris Proteolab Ag | Muteins of apolipoprotein d |
| WO2003029462A1 (en) | 2001-09-27 | 2003-04-10 | Pieris Proteolab Ag | Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| US20030186374A1 (en) | 2001-10-01 | 2003-10-02 | Hufton Simon E. | Multi-chain eukaryotic display vectors and uses thereof |
| DE10230147A1 (de) | 2001-10-09 | 2004-01-15 | Profos Ag | Verfahren zur unspezifischen Anreicherung von Bakterienzellen |
| DE10230997A1 (de) | 2001-10-26 | 2003-07-17 | Ribopharma Ag | Medikament zur Erhöhung der Wirksamkeit eines Rezeptor-vermittelt Apoptose in Tumorzellen auslösenden Arzneimittels |
| US7985553B2 (en) | 2001-10-29 | 2011-07-26 | Nathaniel Heintz | Method for isolating cell type-specific mRNAs |
| DE50307984D1 (de) | 2002-03-01 | 2007-09-27 | Volker A Erdmann | Streptavidin-Bindungspeptid |
| EP1492811B1 (en) | 2002-03-19 | 2011-09-21 | Cincinnati Childrens's Hospital Medical Center | Muteins of the c5a anaphylatoxin, nucleic acid molecules encoding such muteins, and pharmaceutical uses of muteins of the c5a anaphylatoxin |
| ES2328345T3 (es) | 2002-04-17 | 2009-11-12 | Bioren, Inc. | Bibliotecas universales para inmunoglobulinas. |
| DE60319259T2 (de) | 2002-06-14 | 2009-03-05 | Dyax Corp., Cambridge | Rekombination von nukleinsäurebibliotheksmitgliedern |
| JP4659453B2 (ja) | 2002-06-24 | 2011-03-30 | ハイグロス・インヴェスト・ゲゼルシャフト・ミット・ベシュレンクトル・ハフツング | エンドトキシンを検出および除去する方法 |
| AU2003255250A1 (en) | 2002-08-08 | 2004-02-25 | Insert Therapeutics, Inc. | Compositions and uses of motor protein-binding moieties |
| US20040067532A1 (en) | 2002-08-12 | 2004-04-08 | Genetastix Corporation | High throughput generation and affinity maturation of humanized antibody |
| US20040197347A1 (en) | 2002-09-23 | 2004-10-07 | Board Of Regents, The University Of Texas System | Methods for vaccine identification and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the herpesvirus family |
| WO2004103269A2 (en) | 2002-10-18 | 2004-12-02 | Macrogenics, Inc. | Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus borrelia |
| US20050233389A1 (en) | 2003-01-09 | 2005-10-20 | Massachusetts Institute Of Technology | Methods and compositions for peptide and protein labeling |
| US7172877B2 (en) | 2003-01-09 | 2007-02-06 | Massachusetts Institute Of Technology | Methods and compositions for peptide and protein labeling |
| EP1588166A4 (en) | 2003-01-09 | 2007-06-27 | Macrogenics Inc | VECTOR SYSTEM WITH DOUBLE EXPRESSION FOR EXPRESSING ANTIBODIES IN BACTERIAL AND MAMMAL CELLS |
| WO2004063351A2 (en) | 2003-01-09 | 2004-07-29 | Macrogenics, Inc. | IDENTIFICATION AND ENGINEERING OF ANTIBODIES WITH VARIANT Fc REGIONS AND METHODS OF USING SAME |
| EP1452601A1 (en) | 2003-02-28 | 2004-09-01 | Roche Diagnostics GmbH | Enhanced expression of fusion polypeptides with a biotinylation tag |
| EP1454981A1 (en) | 2003-03-03 | 2004-09-08 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Infectious pestivirus pseudo-particles containing functional erns, E1, E2 envelope proteins |
| US20060024676A1 (en) | 2003-04-14 | 2006-02-02 | Karen Uhlmann | Method of detecting epigenetic biomarkers by quantitative methyISNP analysis |
| WO2004099384A2 (en) | 2003-05-02 | 2004-11-18 | Sigma-Aldrich Co. | Solid phase cell lysis and capture platform |
| CA2525120C (en) * | 2003-05-14 | 2013-04-30 | Domantis Limited | A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire |
| JP2007530913A (ja) | 2003-07-10 | 2007-11-01 | ブラインド・ピッグ・プロテオミクス・インコーポレーテッド | 結合の普遍的な検出 |
| WO2005007121A2 (en) | 2003-07-18 | 2005-01-27 | Massachusetts Institute Of Technology | Mutant interleukin-2(il-2) polypeptides |
| EP1503161A3 (en) | 2003-08-01 | 2006-08-09 | Asahi Glass Company Ltd. | Firing container for silicon nitride ceramics |
| EP2824190A1 (en) | 2003-09-09 | 2015-01-14 | Integrigen, Inc. | Methods and compositions for generation of germline human antibody genes |
| CA2543360A1 (en) | 2003-10-24 | 2005-05-06 | Joost A. Kolkman | Ldl receptor class a and egf domain monomers and multimers |
| AU2004297616B2 (en) | 2003-12-04 | 2008-12-18 | Xencor, Inc. | Methods of generating variant proteins with increased host string content and compositions thereof |
| US20050191710A1 (en) | 2004-03-01 | 2005-09-01 | Hanrahan John W. | Method for labeling a membrane-localized protein |
| WO2006026248A1 (en) | 2004-08-25 | 2006-03-09 | Sigma-Aldrich Co. | Compositions and methods employing zwitterionic detergent combinations |
| WO2006044078A2 (en) | 2004-09-17 | 2006-04-27 | Pacific Biosciences Of California, Inc. | Apparatus and method for analysis of molecules |
| WO2006069331A2 (en) | 2004-12-22 | 2006-06-29 | The Salk Institute For Biological Studies | Compositions and methods for producing recombinant proteins |
| EP1848672A4 (en) | 2005-02-01 | 2009-11-04 | Morphosys Ag | BANKS AND METHODS FOR ISOLATING ANTIBODIES |
| US20080206239A1 (en) | 2005-02-03 | 2008-08-28 | Antitope Limited | Human Antibodies And Proteins |
| US20070141548A1 (en) | 2005-03-11 | 2007-06-21 | Jorg Kohl | Organ transplant solutions and method for transplanting organs |
| US20090275481A1 (en) | 2005-06-17 | 2009-11-05 | Pfizer, Inc. | Anchored Transferrin Fusion Protein Libraries |
| WO2007056441A2 (en) * | 2005-11-07 | 2007-05-18 | Genentech, Inc. | Binding polypeptides with diversified and consensus vh/vl hypervariable sequences |
| CA2631327C (en) * | 2005-12-02 | 2015-10-13 | Genentech, Inc. | Her2 binding polypeptides and uses thereof |
| DK1979378T3 (da) * | 2005-12-20 | 2012-10-29 | Morphosys Ag | Ny samling af HCDR3 områder og anvendelser derfor |
| US20070275416A1 (en) | 2006-05-16 | 2007-11-29 | Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh | Affinity marker for purification of proteins |
| WO2008019366A2 (en) | 2006-08-07 | 2008-02-14 | Ludwig Institute For Cancer Research | Methods and compositions for increased priming of t-cells through cross-presentation of exogenous antigens |
| US8807164B2 (en) | 2006-08-30 | 2014-08-19 | Semba Biosciences, Inc. | Valve module and methods for simulated moving bed chromatography |
| US7790040B2 (en) | 2006-08-30 | 2010-09-07 | Semba Biosciences, Inc. | Continuous isocratic affinity chromatography |
| US7806137B2 (en) | 2006-08-30 | 2010-10-05 | Semba Biosciences, Inc. | Control system for simulated moving bed chromatography |
| EP2069558B1 (en) | 2006-10-02 | 2013-05-01 | Sea Lane Biotechnologies,llc. | Design and construction of diverse synthetic peptide and polypeptide libraries |
| CA2671264C (en) | 2006-11-30 | 2015-11-24 | Research Development Foundation | Improved immunoglobulin libraries |
| WO2008100624A2 (en) | 2007-02-16 | 2008-08-21 | Merrimack Pharmaceuticals, Inc. | Antibodies against erbb3 and uses thereof |
| DK3124497T3 (da) | 2007-09-14 | 2020-05-11 | Adimab Llc | Rationelt designede syntetiske antistofbiblioteker og anvendelser deraf |
| US8877688B2 (en) | 2007-09-14 | 2014-11-04 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
| US8067339B2 (en) | 2008-07-09 | 2011-11-29 | Merck Sharp & Dohme Corp. | Surface display of whole antibodies in eukaryotes |
| WO2010059315A1 (en) | 2008-11-18 | 2010-05-27 | Merrimack Pharmaceuticals, Inc. | Human serum albumin linkers and conjugates thereof |
| WO2011032181A2 (en) | 2009-09-14 | 2011-03-17 | Dyax Corp. | Libraries of genetic packages comprising novel hc cdr3 designs |
| US20110189183A1 (en) | 2009-09-18 | 2011-08-04 | Robert Anthony Williamson | Antibodies against candida, collections thereof and methods of use |
| US9051375B2 (en) | 2010-12-21 | 2015-06-09 | The University Of Western Ontario | Alkali-resistant variants of protein A and their use in affinity chromatography |
| WO2012094653A2 (en) | 2011-01-07 | 2012-07-12 | Massachusetts Institute Of Technology | Compositions and methods for macromolecular drug delivery |
| SG186552A1 (en) | 2011-06-08 | 2013-01-30 | Emd Millipore Corp | Chromatography matrices including novel staphylococcus aureus protein a based ligands |
-
2008
- 2008-09-12 DK DK16169483.1T patent/DK3124497T3/da active
- 2008-09-12 CA CA2964398A patent/CA2964398C/en active Active
- 2008-09-12 EP EP20161796.6A patent/EP3753947A1/en active Pending
- 2008-09-12 JP JP2010525049A patent/JP5933894B2/ja active Active
- 2008-09-12 MX MX2013010158A patent/MX344415B/es unknown
- 2008-09-12 BR BRPI0816785A patent/BRPI0816785A2/pt not_active Application Discontinuation
- 2008-09-12 AU AU2008298603A patent/AU2008298603B2/en active Active
- 2008-09-12 US US12/210,072 patent/US8691730B2/en active Active
- 2008-09-12 CA CA3187687A patent/CA3187687A1/en active Pending
- 2008-09-12 EP EP08830652.7A patent/EP2193146B1/en active Active
- 2008-09-12 CN CN200880116593.0A patent/CN101855242B/zh active Active
- 2008-09-12 WO PCT/US2008/076300 patent/WO2009036379A2/en active Application Filing
- 2008-09-12 CA CA2697193A patent/CA2697193C/en active Active
- 2008-09-12 MX MX2010002661A patent/MX2010002661A/es active IP Right Grant
- 2008-09-12 EP EP16169483.1A patent/EP3124497B1/en active Active
-
2010
- 2010-03-09 MX MX2021006269A patent/MX2021006269A/es unknown
-
2011
- 2011-02-15 HK HK11101445.6A patent/HK1147271A1/xx unknown
-
2014
- 2014-01-08 US US14/150,129 patent/US10189894B2/en active Active
- 2014-10-30 JP JP2014220988A patent/JP6383640B2/ja active Active
-
2016
- 2016-05-06 JP JP2016092989A patent/JP6434447B2/ja active Active
-
2017
- 2017-11-02 JP JP2017212474A patent/JP6685267B2/ja active Active
-
2018
- 2018-12-10 US US16/215,523 patent/US11008383B2/en active Active
-
2020
- 2020-03-31 JP JP2020062671A patent/JP6997246B2/ja active Active
-
2021
- 2021-12-16 JP JP2021204097A patent/JP2022040137A/ja not_active Withdrawn
-
2023
- 2023-08-30 US US17/856,673 patent/US20230399386A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3124497T3 (da) | Rationelt designede syntetiske antistofbiblioteker og anvendelser deraf | |
| DK2209806T3 (da) | Anti-hepcidin-antistoffer og anvendelser deraf | |
| DK2059535T3 (da) | Prlr-specifikt antistof og anvendelser deraf | |
| DK2356270T3 (da) | Kombinatoriske antistofbiblioteker og anvendelser deraf | |
| DK2068887T3 (da) | SP35-antistoffer og anvendelser heraf | |
| DK1994055T3 (da) | Anti-5t4-antistoffer og anvendelser deraf | |
| DK1904104T3 (da) | SP35-antistoffer og anvendelser heraf | |
| DK2118140T3 (da) | Humancytomegalovirus-neutraliserende antistoffer og anvendelse deraf | |
| DK2099826T3 (da) | Anti-beta-amyloid-antistof og anvendelser deraf | |
| DK2328931T3 (da) | Selektive anti-hepcidin-25-antistoffer og anvendelser deraf | |
| DK2993187T3 (da) | Antistoffer rettet mod her-3 og anvendelser deraf | |
| DK2283041T3 (da) | Humaniserede anti-faktor d-antistoffer og anvendelser deraf | |
| DK1866339T3 (da) | GTR-bindende molekyler og anvendelser heraf | |
| DK2139490T3 (da) | Diazo-bicykliske smac-mimetiske stoffer og anvendelser deraf | |
| DK2147096T3 (da) | Modificerede faktor-VII-polypeptider og anvendelser deraf | |
| BRPI0807710A2 (pt) | Anticorpos manipulados anti-il-23p19 | |
| DK3339323T3 (da) | Anti-n3pglu-amyloid-beta-peptid-antistoffer og anvendelser deraf | |
| DK3020729T3 (da) | Antistoffer mod human il-22 og anvendelser deraf | |
| NO344992B1 (no) | Anti-GM-CSF antistoffer og anvendelser for disse | |
| DK2913344T3 (da) | Specifikke bindingsproteiner og anvendelser deraf | |
| DK2012773T3 (da) | Lægemidler og anvendelser deraf | |
| DK2142529T3 (da) | Trpv1-antagonister og anvendelser deraf | |
| DK2786762T3 (da) | Kovalente diabodies og anvendelser deraf | |
| BRPI0809677A2 (pt) | Anticorpos anti-ige | |
| DK3002298T3 (da) | Anti-faktor xi monoklonale antistoffer og fremgangsmåder til anvendelse deraf |